Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Relapsed/Refractory Multiple Myeloma
NCT00066638Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2003
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in multiple myeloma (MM), sponsored by National Cancer Institute. Started Jun 2003; status: completed.
02
Drugs
romidepsin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00066638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066638.